Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-13-000336
Filing Date
2013-03-05
Accepted
2013-03-05 20:27:38
Documents
2
Period of Report
2013-03-03

Document Format Files

Seq Description Document Type Size
1 form4-03062013_010326.html 4  
1 form4-03062013_010326.xml 4 4701
2 ex24-03062013_010326.htm EX-24 5715
  Complete submission text file 0001415889-13-000336.txt   11897
Mailing Address 5 CENTERPOINTE DRIVE SUITE 400 LAKE OSWEGO OR 97035
Business Address
DOTSON JERROLD DUANE (Reporting) CIK: 0001388853 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54014 | Film No.: 13667934

Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations